Passage Bio
PASG
NASDAQ
IPO2020
about PASG
Passage Bio is a biotechnology company dedicated to developing gene therapies that treat rare genetic disorders, utilizing adeno-associated viral vectors to deliver therapeutic genes.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $15.39 | $19.22 | $15.39 | $51.21M | 268.96K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$2.44 | n/a | n/a | 0% | 0% | 0% |